🌐 German Healthcare Delegation in Taiwan – A Week of Innovation & Exchange From May 21 to 23, five German companies from the pharmaceutical and biotechnology sectors visited Taiwan as part of the Foreign Market Entry Programme, funded by the German Federal Ministry for Economic Affairs and Energy (BMWE). It is part of the export initiative HEALTH MADE IN GERMANY (Exportinitiative Gesundheitswirtschaft) and is carried out as part of the Ministry's Foreign Market Entry Programme for SMEs. Their goal: exploring collaboration opportunities with Taiwanese industry leaders in innovative drug development, clinical research, and medical technology. Over the course of three days, the delegation participated in over 20 B2B meetings with key Taiwanese counterparts, including Bora Pharmaceuticals, Mycenax Biotech Inc., NHRI, JJP Architects + Planners, and visits to the Hsinchu Biomedical Science Park. One of the highlights was the Taiwan–Germany Biopharmaceutical Industry Meet-Up, hosted together with the Institute for Biotechnology and Medicine Industry (IBMI) and co-hosted by Taipei BioInnovation Park (TBIP). The event featured valuable insights from Dr. Chung-Liang Chien, CEO of IBMI, and Dr. Jenny Yang, Vice President at Century Biotech Development Corporation. We would especially like to thank Michelle Wang, Senior Manager at IBMI’s International Cooperation Department, for her pivotal role in making this exchange happen and moderating the session. We were honored to support this vibrant delegation and thank all partners involved. With both sides sharing a commitment to innovation and internationalization, this visit once again highlighted the strong potential for future Taiwan–Germany partnerships in the life sciences. If you’re considering exploring the Taiwanese market, feel free to reach out — we’re happy to support your first steps and share how we assist German companies with market entry and local connections. Link in the comments. 🌐 德國醫療產業代表團訪台──為期一週的創新交流之旅 5/21-5/23日,來自德國的五家製藥與生技公司駔成代表團,來台進行為期三天的交流訪問。本次行程是德國聯邦經濟暨能源部(BMWE)「HEALTH MADE IN GERMANY」出口計畫的一部分,並納入中小企業海外市場拓展計劃中,旨在與台灣產業領導者探討創新藥物研發、臨床研究與醫療技術領域的合作機會。 在三天的密集行程中,代表團與多家台灣重要產業夥伴進行超過20場一對一商務媒合會(B2B meetings),交流對象包括:保瑞藥業、永昕生物醫藥、國家衛生研究院、潘冀聯合建築師事務所,以及新竹生醫園區等。 行程亮點之一為「台德生技製藥產業交流會」,由生物技術與醫藥產業策進會(IBMI)主辦、台北生技園區(TBIP)協辦。會中邀請IBMI執行長錢宗良執行長以及TBIP楊家琳博士分享產業趨勢與合作契機,特別感謝IBMI國際合作部王秉慧經理的用心安排與精采主持,促成本次深度對話。 我們很榮幸能支持這場充滿活力的代表團交流,也感謝所有合作夥伴的熱情參與。台德雙方對創新與國際化有著相同的投入,此次訪問再次展現未來雙邊在生命科學領域合作的強大潛力。 若您有意拓展台灣市場,歡迎與我們聯繫,我們樂意協助德國企業邁出第一步,建立在地連結。詳情請見留言區連結。 #PartnerInTaiwan #Biotech #Pharmaceuticals #LifeSciences #GermanyTaiwan #HealthcareInnovation #Delegation #MarketEntry #InternationalCooperation
-
-
-
-
-
+9